Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zura Bio Ltd | Chief Executive Officer | Employee Share Option (Right to Buy) | 1.05M | Jun 18, 2024 | Direct | ||
Zura Bio Ltd | Chief Executive Officer | Stock options | 1M | Jan 24, 2024 | Direct | ||
Cadrenal Therapeutics, Inc. | Director | Stock Options | 50K | Jan 18, 2024 | Direct | ||
ARENA PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Common Stock | 0 | $98.51 | Mar 11, 2022 | Direct | |
ARENA PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Employee Performance Restricted Stock Unit | 0 | Mar 11, 2022 | Direct | ||
ARENA PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Employee Stock Option (right to buy) | 0 | Mar 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZURA | Zura Bio Ltd | Jun 18, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Chief Executive Officer |
ZURA | Zura Bio Ltd | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | President, Chief Operating Officer |
CVKD | Cadrenal Therapeutics, Inc. | Jan 18, 2024 | 1 | $0 | 4 | Jan 19, 2024 | Director |
ZURA | Zura Bio Ltd | Jan 8, 2024 | 0 | $0 | 3 | Jan 8, 2024 | President, Chief Operating Officer |
CVKD | Cadrenal Therapeutics, Inc. | Jul 23, 2023 | 1 | $0 | 4 | Jul 24, 2023 | Director |
CVKD | Cadrenal Therapeutics, Inc. | Jul 23, 2023 | 0 | $0 | 3 | Jul 24, 2023 | Director |
ARNA | ARENA PHARMACEUTICALS INC | Mar 11, 2022 | 8 | $0 | 4 | Mar 11, 2022 | EVP, Chief Commercial Officer |
ARNA | ARENA PHARMACEUTICALS INC | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | EVP, Chief Commercial Officer |
ARNA | ARENA PHARMACEUTICALS INC | Aug 3, 2021 | 4 | -$335K | 4 | Aug 5, 2021 | EVP, Chief Commercial Officer |